$1.01 0.02 (+2.21%)
11/9/2009 11:06 AM

Cell Therapeutics, Inc. (CTIC)

CAPS Rating: 3 out of 5

The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.

Current Price $1.01 Mkt Cap $546.58M
Open $1.00 P/E Ratio 0.15
Prev. Close $0.99 Div. (Yield) N/A (N/A)
Daily Range $1.00 - $1.02 Volume 2,928,419
52-Wk Range $0.05 - $2.23 Avg. Daily Vol. 17,702,000

CTIC News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

221 Outperform
25 Underperform
 

All-Star Members

51 Outperform
10 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top CTIC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dbbfool63 (97.96)
Submitted August 27, 2009

Good entry point for mid to long term.

I couldn't get in until it got above a dollar to rate it although been watching since .o7/shr.

Probably could of got in lower, but lost track watching others.

0 Comments | Reply | Report this Post

kanstockman (< 20)
Submitted June 11, 2007

2008 a drug in Phase III stage II should be on the market with a half a billion in sales by the 2nd Q. Right now the stock is being dragged down by the sector componants.

2 Comments | Reply | Report this Post
CTIC VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about CTIC.

Recs

0
Member Avatar libertybrewcity (< 20) Submitted: 9/3/2009 12:59:57 AM : Outperform Start Price: $1.53 CTIC Score: -42.69

The new drug is about to go into phase 3 and the stock will explode!

Report this Post 2 Comments | Reply | Permalink

Recs

0
Member Avatar PicoTrader (< 20) Submitted: 9/1/2009 3:36:24 PM : Outperform Start Price: $1.52 CTIC Score: -42.11

cancer drugs in the pipeline with possible good outcomes.....

Report this Post 0 Comments | Reply | Permalink

Recs

2
Member Avatar dbbfool63 (97.96) Submitted: 8/27/2009 6:28:48 PM : Outperform Start Price: $1.59 CTIC Score: -41.19

Good entry point for mid to long term.

I couldn't get in until it got above a dollar to rate it although been watching since .o7/shr.

Probably could of got in lower, but lost track watching others.

Report this Post 0 Comments | Reply | Permalink
View All 51 Pitches »

Leaderboard

Find the members with the highest scoring picks in CTIC.

Score Leader

BenBernanke

BenBernanke (84.97) Score: +91.38

The Score Leader is the member with the highest score across all their picks in CTIC.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
TMFNosediveflip 97.35 9/20/2006 Underperform 1Y $7.20 -85.97% -12.82% +73.15
cockeagledrvr 50.55 9/29/2006 Underperform 1Y $6.96 -85.49% -13.81% +71.67
tomgross12 53.83 12/8/2006 Underperform 1Y $7.52 -86.57% -18.29% +68.28
mcornice 77.73 6/2/2009 Underperform 3M $2.01 -49.75% +16.26% +66.02
RoxanneAdams 56.71 6/3/2009 Underperform 5Y $1.94 -47.94% +16.71% +64.65
proud174 73.62 2/16/2007 Underperform 1Y $6.36 -84.12% -20.73% +63.39
TMFCop 77.32 6/2/2009 Underperform 1Y $1.93 -47.67% +15.73% +63.39
f19 < 20 6/4/2009 Underperform 3M $1.85 -45.41% +16.76% +62.17 1 Comment
elizabethforman1 < 20 4/19/2007 Underperform NS $5.71 -82.31% -22.05% +60.26
ed11b < 20 6/26/2009 Underperform 5Y $1.68 -39.88% +19.10% +58.97
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackZacks 72.72 1/16/2008 Outperform 3M $1.50 -62.67% -2.45% -60.22 3/18/2008 @ $0.56 1 Comment
TrackRodmanRen < 20 1/8/2007 Outperform NS $6.96 -85.49% -18.12% -67.37

Featured Broker Partners